Expertise in
4
conditions

Dr. Katherine S. Taub

Pediatric Neurology | Neurology
3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Neurology, 
Philadelphia, PA 
Expertise in
4
conditions
3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Neurology, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Katherine Taub is a Pediatric Neurologist and a Neurologist in Philadelphia, Pennsylvania. Dr. Taub is highly rated in 4 conditions, according to our data. Her top areas of expertise are Tuberous Sclerosis, Tuberous Sclerosis Complex, Cortical Dysplasia, and West Syndrome.

Her clinical research consists of co-authoring 5 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Neurology
Neurology
Licenses
Neurology with Special Qualifications in Neurology in PA
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Neurology, Philadelphia, PA 19104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

An Open-label, Multi-center Long-term Safety Roll-over Study in Patients With Tuberous Sclerosis Complex (TSC) and Refractory Seizures Who Are Judged by the Investigator to Benefit From Continued Treatment With Everolimus After Completion of Study CRAD001M2304.
An Open-label, Multi-center Long-term Safety Roll-over Study in Patients With Tuberous Sclerosis Complex (TSC) and Refractory Seizures Who Are Judged by the Investigator to Benefit From Continued Treatment With Everolimus After Completion of Study CRAD001M2304.
Enrollment Status: Active_not_recruiting
Publish Date: May 28, 2025
Intervention Type: Drug
Study Drug: Everolimus
Study Phase: Phase 3
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex (PREVeNT Trial) A Randomized, Double-blind, Placebo-controlled Seizure Prevention Clinical Trial for Infants With TSC
Preventing Epilepsy Using Vigabatrin In Infants With Tuberous Sclerosis Complex (PREVeNT Trial) A Randomized, Double-blind, Placebo-controlled Seizure Prevention Clinical Trial for Infants With TSC
Enrollment Status: Completed
Publish Date: August 19, 2024
Intervention Type: Drug
Study Drug: Vigabatrin
Study Phase: Phase 2
Phase 2 Multi Center Prospective Rand. Double Blind Placebo Cont. Parallel Design Study to Evaluate Safety & Efficacy of Topical Sirolimus for Cutaneous Angiofibromas in Subjects W/ Tuberous Sclerosis Complex Followed by Opt. Open Label
Phase 2 Multi Center Prospective Rand. Double Blind Placebo Cont. Parallel Design Study to Evaluate Safety & Efficacy of Topical Sirolimus for Cutaneous Angiofibromas in Subjects W/ Tuberous Sclerosis Complex Followed by Opt. Open Label
Enrollment Status: Terminated
Publish Date: March 30, 2023
Intervention Type: Drug
Study Drug: Sirolimus
Study Phase: Phase 2
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
A Three-arm, Randomized, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Two Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) Who Have Refractory Partial-onset Seizures
Enrollment Status: Completed
Publish Date: November 07, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

5 Total Publications

Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial.
Drug-Resistant Epilepsy in Tuberous Sclerosis Complex Is Associated With TSC2 Genotype: More Findings From the Preventing Epilepsy Using Vigatrin (PREVeNT) Trial.
Journal: Pediatric neurology
Published: March 05, 2024
Similar Doctors
Expertise in
22
conditions
Dr. Adeline L. Vanderver
Pediatric Neurology | Neurology
Expertise in
22
conditions
Dr. Adeline L. Vanderver
Pediatric Neurology | Neurology
3401 Civic Center Blvd, 
Philadelphia, PA 
 (0.1 mi)
215-590-1000
Languages Spoken:
English

Adeline Vanderver is a Pediatric Neurologist and a Neurologist in Philadelphia, Pennsylvania. Dr. Vanderver is highly rated in 22 conditions, according to our data. Her top areas of expertise are Aicardi-Goutieres Syndrome, Leukodystrophy, CACH Syndrome, and Pol 3-Related Leukodystrophy.

Expertise in
16
conditions
Dr. Dennis J. Dlugos
Pediatric Neurology | Pediatrics | Neurology
Expertise in
16
conditions
Dr. Dennis J. Dlugos
Pediatric Neurology | Pediatrics | Neurology
3401 Civic Center Blvd, Children's Hospital Of Philadelphia - Neurology, 
Philadelphia, PA 
 (0.1 mi)
215-590-1719
Languages Spoken:
English
See accepted insurances

Dennis Dlugos is a Pediatric Neurologist and a Pediatrics provider in Philadelphia, Pennsylvania. Dr. Dlugos is highly rated in 16 conditions, according to our data. His top areas of expertise are Seizures, Epilepsy, West Syndrome, and Spasmus Nutans.

Expertise in
9
conditions
Dr. Nicholas S. Abend
Pediatric Neurology | Pediatrics | Neurology
Expertise in
9
conditions
Dr. Nicholas S. Abend
Pediatric Neurology | Pediatrics | Neurology

Childrens Health Care Associates Inc

3401 Civic Ctr Blvd, 
Philadelphia, PA 
 (0.1 mi)
215-590-1000
Languages Spoken:
English
See accepted insurances

Nicholas Abend is a Pediatric Neurologist and a Pediatrics provider in Philadelphia, Pennsylvania. Dr. Abend is highly rated in 9 conditions, according to our data. His top areas of expertise are Status Epilepticus, Seizures, Epilepsy in Children, and Epilepsy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Taub's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile